Marine‐derived n‐3 fatty acids therapy vs No marine‐derived n‐3 fatty acids therapy
Recurrent events (both ischaemic and haemorrhagic stroke) · stroke and/or TIA
Marine‐derived n‐3 fatty acids therapy showed no clear difference in recurrent events (both ischaemic and haemorrhagic stroke) compared with no marine‐derived n‐3 fatty acids therapy (low certainty).
1 finding from 1 review
- RR 0.69 [0.31, 1.55]3 studies · 1819 participantsLow